131 related articles for article (PubMed ID: 33518858)
1. Structure features of peptide-type SARS-CoV main protease inhibitors: Quantitative structure activity relationship study.
Masand VH; Akasapu S; Gandhi A; Rastija V; Patil MK
Chemometr Intell Lab Syst; 2020 Nov; 206():104172. PubMed ID: 33518858
[TBL] [Abstract][Full Text] [Related]
2. Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches.
Bakal RL; Jawarkar RD; Manwar JV; Jaiswal MS; Ghosh A; Gandhi A; Zaki MEA; Al-Hussain S; Samad A; Masand VH; Mukerjee N; Nasir Abbas Bukhari S; Sharma P; Lewaa I
Saudi Pharm J; 2022 Jun; 30(6):693-710. PubMed ID: 35812153
[TBL] [Abstract][Full Text] [Related]
3. Extending the identification of structural features responsible for anti-SARS-CoV activity of peptide-type compounds using QSAR modelling.
Masand VH; Rastija V; Patil MK; Gandhi A; Chapolikar A
SAR QSAR Environ Res; 2020 Sep; 31(9):643-654. PubMed ID: 32847369
[TBL] [Abstract][Full Text] [Related]
4. Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis.
Zaki MEA; Al-Hussain SA; Masand VH; Akasapu S; Bajaj SO; El-Sayed NNE; Ghosh A; Lewaa I
Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33924395
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Structure-Activity Relationship Evaluation of MDA-MB-231 Cell Anti-Proliferative Leads.
Gandhi A; Masand V; Zaki MEA; Al-Hussain SA; Ghorbal AB; Chapolikar A
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443383
[TBL] [Abstract][Full Text] [Related]
6. QSAR study of unsymmetrical aromatic disulfides as potent avian SARS-CoV main protease inhibitors using quantum chemical descriptors and statistical methods.
Chtita S; Belhassan A; Bakhouch M; Taourati AI; Aouidate A; Belaidi S; Moutaabbid M; Belaaouad S; Bouachrine M; Lakhlifi T
Chemometr Intell Lab Syst; 2021 Mar; 210():104266. PubMed ID: 33558778
[No Abstract] [Full Text] [Related]
7. Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations.
Oubahmane M; Hdoufane I; Delaite C; Sayede A; Cherqaoui D; El Allali A
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111365
[TBL] [Abstract][Full Text] [Related]
8. QSAR Evaluations to Unravel the Structural Features in Lysine-Specific Histone Demethylase 1A Inhibitors for Novel Anticancer Lead Development Supported by Molecular Docking, MD Simulation and MMGBSA.
Jawarkar RD; Bakal RL; Mukherjee N; Ghosh A; Zaki MEA; Al-Hussain SA; Al-Mutairi AA; Samad A; Gandhi A; Masand VH
Molecules; 2022 Jul; 27(15):. PubMed ID: 35897936
[TBL] [Abstract][Full Text] [Related]
9. QSAR and Pharmacophore Modeling of Nitrogen Heterocycles as Potent Human
Zaki MEA; Al-Hussain SA; Masand VH; Akasapu S; Lewaa I
Molecules; 2021 Mar; 26(7):. PubMed ID: 33805223
[No Abstract] [Full Text] [Related]
10. Combining docking, molecular dynamics simulations, AD-MET pharmacokinetics properties, and MMGBSA calculations to create specialized protocols for running effective virtual screening campaigns on the autoimmune disorder and SARS-CoV-2 main protease.
Edache EI; Uzairu A; Mamza PA; Shallangwa GA; Yagin FH; Abdel Samee N; Mahmoud NF
Front Mol Biosci; 2023; 10():1254230. PubMed ID: 37771457
[TBL] [Abstract][Full Text] [Related]
11. QSAR analysis of sodium glucose co-transporter 2 (SGLT2) inhibitors for anti-hyperglycaemic lead development.
Gandhi A; Masand V; Zaki MEA; Al-Hussain SA; Ghorbal AB; Chapolikar A
SAR QSAR Environ Res; 2021 Sep; 32(9):731-744. PubMed ID: 34494464
[TBL] [Abstract][Full Text] [Related]
12. QSAR, homology modeling, and docking simulation on SARS-CoV-2 and pseudomonas aeruginosa inhibitors, ADMET, and molecular dynamic simulations to find a possible oral lead candidate.
Edache EI; Uzairu A; Mamza PA; Shallangwa GA
J Genet Eng Biotechnol; 2022 Dec; 20():88. PubMed ID: 35730025
[TBL] [Abstract][Full Text] [Related]
13. COVID-19: In silico identification of potent α-ketoamide inhibitors targeting the main protease of the SARS-CoV-2.
Oubahmane M; Hdoufane I; Bjij I; Jerves C; Villemin D; Cherqaoui D
J Mol Struct; 2021 Nov; 1244():130897. PubMed ID: 34149065
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic and Predictive QSAR Analysis of Diverse Molecules to Capture Salient and Hidden Pharmacophores for Anti-Thrombotic Activity.
Zaki MEA; Al-Hussain SA; Masand VH; Sabnani MK; Samad A
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361118
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic Analysis of Chemically Diverse Bromodomain-4 Inhibitors Using Balanced QSAR Analysis and Supported by X-ray Resolved Crystal Structures.
Zaki MEA; Al-Hussain SA; Al-Mutairi AA; Masand VH; Samad A; Jawarkar RD
Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745664
[TBL] [Abstract][Full Text] [Related]
16. Development of a simple, interpretable and easily transferable QSAR model for quick screening antiviral databases in search of novel 3C-like protease (3CLpro) enzyme inhibitors against SARS-CoV diseases.
Kumar V; Roy K
SAR QSAR Environ Res; 2020 Jul; 31(7):511-526. PubMed ID: 32543892
[TBL] [Abstract][Full Text] [Related]
17. QSAR, Molecular Docking, MD Simulation and MMGBSA Calculations Approaches to Recognize Concealed Pharmacophoric Features Requisite for the Optimization of ALK Tyrosine Kinase Inhibitors as Anticancer Leads.
Jawarkar RD; Sharma P; Jain N; Gandhi A; Mukerjee N; Al-Mutairi AA; Zaki MEA; Al-Hussain SA; Samad A; Masand VH; Ghosh A; Bakal RL
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956900
[TBL] [Abstract][Full Text] [Related]
18.
Khan PM; Kumar V; Roy K
Comb Chem High Throughput Screen; 2021; 24(8):1281-1299. PubMed ID: 32928086
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore Synergism in Diverse Scaffold Clinches in Aurora Kinase B.
Masand VH; Al-Hussain SA; Rathore MM; Thakur SD; Akasapu S; Samad A; Al-Mutairi AA; Zaki MEA
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498857
[TBL] [Abstract][Full Text] [Related]
20. Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some
Amin SA; Ghosh K; Gayen S; Jha T
J Biomol Struct Dyn; 2021 Aug; 39(13):4764-4773. PubMed ID: 32568618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
